Globe Roche Logo

cobas® HCV Test

Inform therapy decisions with innovative, state-of-the-art, dual-probe HCV viral load testing for the cobas® 4800/6800/8800 Systems

More

COBAS® AmpliPrep/COBAS® TaqMan® HCV Test, v2.0: Qualitative and Quantitative

Accurately detect HCV and confidently monitor viral load results.

More

Hepatitis C (HCV)

Approximately 130–150 million people globally have a chronic hepatitis C infection, with 3 to 4 million new infections occurring each year.1

More

cobas®  HCV GT for use on the cobas®  4800 System

Test for the qualitative identification of HCV genotypes 1 to 6 and genotype 1 subtypes a and b in…

More

COBAS® AmpliScreen HCV Test, v2.0

A PCR test that detects the presence of HCV RNA in plasma of blood, organ and tissue donors.

More

cobas® MPX Test

Detects and discriminates the most critical viral targets in one easy-to-use assay.

More

COBAS® TaqMan® HCV Test v2.0 For Use With The High Pure System

Utilizes real-time PCR technology for the detection and quantitation of HCV RNA genotypes 1-6 as an aid…

More

cobas® TaqScreen MPX Test

A multiplex, real-time PCR test that detects the presence of human immunodeficiency virus type 1 (HIV-1, groups M and O), human immunodeficiency virus type 2 (HIV-2), hepatitis C virus (HCV) and hepatitis B virus…

More

Roche expands cobas® 4800 System menu with HIV-1, HCV and HCV Genotyping Tests

System portfolio broadens to include high medical value virology assays

Explore

Roche receives FDA approval for viral load tests and cobas® 6800/8800 Systems

Roche receives FDA approval for viral load tests and cobas® 6800/8800 Systems. cobas®6800/8800 Systems offer fastest time to results and highest throughput of any molecular platform, helping to improve disease management and patient care.

Explore

Roche launches next-generation duplex test for parvovirus B19 and hepatitis A in markets accepting the CE mark

Cobas® DPX assay increases safety of human plasma and plasma products

Explore

Roche launches next-generation viral load testing assays for new molecular diagnostic platforms in markets accepting the CE mark

cobas HIV-1 and HCV assays offer unparalleled performance on cobas 6800/8800 Systems.

Explore

FDA approves new Roche test to evaluate response to hepatitis C therapy

Viral load test uses a novel dual-probe approach designed to manage patients being treated with antiviral therapies

Explore

Roche’s novel tests for the management of hepatitis C virus infection receive CE Mark

Tests change hepatitis C disease and patient management

Explore

Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Mark

cobas® TaqScreen MPX Test, v2.0[1] provides real-time results for HIV, HCV and HBV

Explore

Roche receives FDA approval for a second-generation hepatitis C viral load test

Another Roche FDA approval in the COBAS® TaqMan® viral load portfolio

Explore

FDA approves use of Roche test to screen source plasma for HIV, hepatitis B virus and hepatitis C virus

cobas® TaqScreen MPX Test is the most comprehensive - detects multiple viruses for increased plasma product safety

Explore

Roche introduces new cobas p 630 Instrument and AMPLILINK 3.3 Series Software with CE Mark

New pre-analytical solution that integrates automated primary tube handling

Explore

Roche receives FDA approval for Hepatitis C viral load test on its fully automated real-time PCR platform

Improved laboratory efficiencies and standardization to personalize patient care

Explore

Roche Diagnostics Submits Hepatitis C Viral Load Monitoring Test to FDA

Test designed to give doctors highly accurate results and to improve workflow efficiency for labs Roche Diagnostics announced today that it has submitted its automated test for Hepatitis C viral load monitoring to the U.S. Food & Drug Administration (FDA) …

Explore